Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Weaver helps a health system evaluate its revenue quality, estimate collections and gain clarity on complex streams.
Weaver's FLS team helped a court-appointed receiver trace millions, uncover assets and secure significant recoveries in a complex Ponzi scheme.
Discover how investigative journalism uncovers fraud and its interplay with forensic accounting in Weaver's latest podcast episode.
Weaver's forensic and litigation services team helped a company win over $2M in a co-owner dispute by uncovering misappropriated funds.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
Public-sector procurement scandals show how lax vendor controls endanger taxpayer dollars. Learn key red flags and practical steps to reduce risk.
Our Health Care Valuation Insights Hub is your go-to resource for knowledge and strategies to stay ahead in an evolving industry.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
See how ambulatory surgery centers (ASC) and imaging center valuation multiples compare, revealing key differences, patterns and transaction risk.
Learn how economists project medical costs in personal injury cases and why accurate forecasting metrics are key to fair plaintiff compensation.
Explore why profitable hospitals command higher valuations and how variability in transaction databases impacts fair market value.